Rm. Orr et al., PHARMACOLOGICAL DISPOSITION OF A PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE IN MICE, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1699-1702
G3139, an 18mer phosphorothioate (S-35-labeled), was administered to m
ice by single i.v. bolus or continuous s.c. infusion. The latter sched
ule resulted in reduced liver metabolism and urinary excretion togethe
r with greater tissue accumulation, in particular to the liver, kidney
and bone marrow, probably reflecting the dose received.